Search Results - "Pirollo, Kathleen"
-
1
Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide
Published in Nucleic acids research (16-02-2018)“…Abstract Intrinsic therapeutic resistance especially in cancer stem cells (CSCs) together with extensive tumor cell infiltration and restricted permeation of…”
Get full text
Journal Article -
2
Effective treatment of glioblastoma requires crossing the blood–brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine
Published in Biochemical and biophysical research communications (18-12-2015)“…Glioblastoma multiforme (GBM) is the most aggressive and lethal type of brain tumor. Both therapeutic resistance and restricted permeation of drugs across the…”
Get full text
Journal Article -
3
Phase I Study of a Systemically Delivered p53 Nanoparticle in Advanced Solid Tumors
Published in Molecular therapy (01-05-2013)“…Selective delivery of therapeutic molecules to primary and metastatic tumors is optimal for effective cancer therapy. A liposomal nanodelivery complex (scL)…”
Get full text
Journal Article -
4
Safety and Efficacy in Advanced Solid Tumors of a Targeted Nanocomplex Carrying the p53 Gene Used in Combination with Docetaxel: A Phase 1b Study
Published in Molecular therapy (01-09-2016)“…Loss of p53 suppressor function, through mutations or inactivation of the p53 pathway, occurs in most human cancers. SGT-53 is a liposomal nanocomplex designed…”
Get full text
Journal Article -
5
Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma
Published in Cancer letters (01-12-2015)“…Highlights • GBM is the most aggressive and lethal type of brain tumor with a poor prognosis. • Novel strategies are needed to improve limited efficacy of TMZ…”
Get full text
Journal Article -
6
A Nanoparticle Carrying the p53 Gene Targets Tumors Including Cancer Stem Cells, Sensitizes Glioblastoma to Chemotherapy and Improves Survival
Published in ACS nano (24-06-2014)“…Temozolomide (TMZ)-resistance in glioblastoma multiforme (GBM) has been linked to upregulation of O 6-methylguanine-DNA methyltransferase (MGMT). Wild-type…”
Get full text
Journal Article -
7
Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer
Published in Clinical cancer research (01-05-2019)“…To identify deregulated and inhibitory miRNAs and generate novel mimics for replacement nanomedicine for head and neck squamous cell carcinomas (HNSCC). We…”
Get full text
Journal Article -
8
TP53 Gene Therapy as a Potential Treatment for Patients with COVID-19
Published in Viruses (31-03-2022)“…SGT-53 is a novel investigational agent that comprises an immunoliposome carrying a plasmid vector driving expression of the human gene that encodes wild-type…”
Get full text
Journal Article -
9
A Pralidoxime Nanocomplex Formulation Targeting Transferrin Receptors for Reactivation of Brain Acetylcholinesterase After Exposure of Mice to an Anticholinesterase Organophosphate
Published in International journal of nanomedicine (01-01-2024)“…Organophosphates are among the deadliest of known chemicals based on their ability to inactivate acetylcholinesterase in neuromuscular junctions and synapses…”
Get full text
Journal Article -
10
scL-2PAM: A Novel Countermeasure That Ameliorates Neuroinflammation and Neuronal Losses in Mice Exposed to an Anticholinesterase Organophosphate
Published in International journal of molecular sciences (01-07-2024)“…Due to their inhibition of acetylcholinesterase, organophosphates are among the most toxic of chemicals. Pralidoxime (a.k.a 2-PAM) is the only…”
Get full text
Journal Article -
11
Targeted Delivery of Small Interfering RNA : Approaching Effective Cancer Therapies
Published in Cancer research (Chicago, Ill.) (01-03-2008)“…Three of the primary requirements for the development of effective dual-targeting therapeutic modalities for the treatment of cancer are the tumor-targeted…”
Get full text
Journal Article -
12
A Phase l Study of a Tumor-targeted Systemic Nanodelivery System, SGT-94, in Genitourinary Cancers
Published in Molecular therapy (01-08-2016)“…Gene therapy development has been limited by our inability to target multifocal cancer with systemic delivery. We developed a systemically administered,…”
Get full text
Journal Article -
13
The Clinical Potential of Targeted Nanomedicine: Delivering to Cancer Stem-like Cells
Published in Molecular therapy (01-02-2014)“…Cancer stem-like cells (CSCs) have been implicated in recurrence and treatment resistance in many human cancers. Thus, a CSC-targeted drug delivery strategy to…”
Get full text
Journal Article -
14
Materializing the potential of small interfering RNA via a tumor-targeting nanodelivery system
Published in Cancer research (Chicago, Ill.) (01-04-2007)“…The field of small interfering RNA (siRNA) as potent sequence-selective inhibitors of transcription is rapidly developing. However, until now, low transfection…”
Get full text
Journal Article -
15
Nanotherapeutics for Gene Modulation that Prevents Apoptosis in the Brain and Fatal Neuroinflammation
Published in Molecular therapy (03-01-2018)“…The failure of therapeutic agents to cross the blood-brain barrier (BBB) has been a major impediment in the treatment of neurological disorders and brain…”
Get full text
Journal Article -
16
Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53‐altered tumors
Published in Cancer (15-07-2019)“…Background Over 96% of high‐grade ovarian carcinomas and 50% of all cancers are characterized by alterations in the p53 gene. Therapeutic strategies to restore…”
Get full text
Journal Article -
17
Nanomedicine-Based Gene Delivery for a Truncated Tumor Suppressor RB94 Promotes Lung Cancer Immunity
Published in Cancers (01-10-2022)“…Because lung cancer remains the most common and lethal of cancers, novel therapeutic approaches are urgently needed. RB94 is a truncated form of retinoblastoma…”
Get full text
Journal Article -
18
A tumor-targeting p53 nanodelivery system limits chemoresistance to temozolomide prolonging survival in a mouse model of glioblastoma multiforme
Published in Nanomedicine (01-02-2015)“…Abstract Development of temozolomide (TMZ) resistance contributes to the poor prognosis for glioblastoma multiforme (GBM) patients. It was previously…”
Get full text
Journal Article -
19
Does a targeting ligand influence nanoparticle tumor localization or uptake?
Published in Trends in biotechnology (Regular ed.) (01-10-2008)“…Inclusion of a tumor-targeting molecule in nanosized delivery systems increases their in vivo efficacy. However, the biodistribution and pharmacokinetics of…”
Get full text
Journal Article -
20
Nanoimmunoliposome delivery of superparamagnetic iron oxide markedly enhances targeting and uptake in human cancer cells in vitro and in vivo
Published in Nanomedicine (01-12-2008)“…Abstract To circumvent the problem of reduction of the supermagnetic properties of superparamagnetic iron oxide (SPIO) nanoparticles after chemical…”
Get full text
Journal Article